Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis

First evidence of ruxolitinib efficacy for subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic lymphohistiocytosis. Supporting rationale for ruxolitinib use, not more aggressive treatment, in this context, questioning this condition’s neoplastic nature.

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Blood Adv
Main Authors: Lévy, Romain, Fusaro, Mathieu, Guerin, Frédéric, Chetouani, Ahmed, Moshous, Despina, Fischer, Alain, de Saint Basile, Geneviève, Sepulveda, Fernando E., Neven, Bénédicte
Formáid: Artigo
Teanga:Inglês
Foilsithe: American Society of Hematology 2020
Ábhair:
Exceptional Case Report
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160282/
https://ncbi.nlm.nih.gov/pubmed/32271897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001497
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla